Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases
Open Access
- 14 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 12 (7), 711-719
- https://doi.org/10.1093/neuonc/noq005
Abstract
Adjuvant whole-brain radiation therapy (WBRT) after resection of single brain metastases remains controversial. Despite a phase III trial to the contrary, clinicians often withhold WBRT after resection of single brain metastases based on the argument that available evidence does not inform regarding treatment of all patients, such as those with radioresistant tumors. However, there is limited information about whether subpopulations benefit equally from WBRT after resection. Therefore, we undertook a retrospective study to determine the clinical, radiographic, and histologic features that influenced the effectiveness of adjuvant WBRT. We reviewed 358 patients with newly diagnosed, single brain metastases, who underwent resection, of which 142 (40%) received adjuvant WBRT and 216 (60%) did not. Median follow-up was 60.1 months. There were multiple tumor histologies, including 197 (55%) "radiosensitive" and 161 (45%) "radioresistant" tumors. Compared with observation, WBRT significantly reduced recurrence both locally (HR = 0.58; 95% CI 0.35–0.98, P = .04) and at distant brain sites (HR = 0.43, 95% CI 0.30–0.61, P < .001). Multivariate analyses demonstrated that withholding WBRT was an independent predictor of local and distant recurrence. For local recurrence, tumors with a maximum diameter of ≥3 cm that did not receive adjuvant WBRT had an increased risk of recurring locally (HR = 3.14, 95% CI 1.02–9.69, P = .05). For distant recurrence, patients whose primary disease was progressing and who did not receive WBRT had an increased risk of distant recurrence (HR = 2.16, 95% CI 1.01–4.66, P = .05). There was no effect of WBRT based on tumor type. Adjuvant WBRT significantly reduces local and distant recurrences in subsets of patients, particularly those with metastases >3 cm or with active systemic disease.Keywords
This publication has 21 references indexed in Scilit:
- Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialThe Lancet Oncology, 2009
- Gamma Knife radiosurgery to the surgical cavity following resection of brain metastasesJournal of Neurosurgery, 2009
- TUMOR BED RADIOSURGERY AFTER RESECTION OF CEREBRAL METASTASESNeurosurgery, 2008
- Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossaJournal of Neurosurgery, 2008
- Comments about the prospective randomized trial by Aoyama et alSurgical Neurology, 2006
- Postoperative Radiotherapy in the Treatment of Single Metastases to the BrainJAMA, 1998
- The role of radiation therapy following resection of single brain metastasis from melanomaNeurology, 1990
- Radiation‐induced dementia in patients cured of brain metastasesNeurology, 1989
- The Role of Postoperative Radiotherapy after Resection of Single Brain MetastasesNeurosurgery, 1989
- Management of solitary metastasis to the brain: The role of elective brain irradiation following complete surgical resectionInternational Journal of Radiation Oncology*Biology*Physics, 1980